UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000023422 |
|---|---|
| Receipt number | R000026986 |
| Scientific Title | A phase two clinical trial of the personalized peptide vaccine for standard therapy-resistant pediatric cancer patients |
| Date of disclosure of the study information | 2016/08/22 |
| Last modified on | 2019/12/18 12:49:52 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/08/01 14:30:45 | ||
| 2 | Update | 2016/08/30 12:14:24 | Interventions/Control_1 Key exclusion criteria |
|
| 3 | Update | 2016/08/30 12:15:04 | Recruitment status |
|
| 4 | Update | 2017/02/03 11:08:14 | Key inclusion criteria |
|
| 5 | Update | 2018/08/10 11:02:13 | ||
| 6 | Update | 2018/08/10 11:05:51 | Recruitment status |
|
| 7 | Update | 2019/12/18 12:49:52 | Recruitment status Date of IRB Last follow-up date |
